It is well understood that IL-two is really a pleiotropic cytokine positioned with the crossroads of T mobile activation and regulation. As such, it's vital to engineer an IL-two molecule that is biased in the direction of effector cells bearing the intermediate affinity receptor, like naïve and memory CD8+ T cells and NK cells, versus Treg cells